The Potency and Efficacy of Losartan and its Metabolites in the Treatment of Pulmonary Hypertension

氯沙坦及其代谢物治疗肺动脉高压的效力和功效

• 批准号: 476069
• 负责人: Evans Alexandria
• 金额: $ 7.65万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-11-01 至 2025-11-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=476069&lang=en
• 关键词: Endothelium; Losartan; Losartan Metabolites; Pulmonary Hypertension

Pulmonary hypertension (PH) is a lung disease characterized by high pressure in the lungs, thickening of the blood vessel walls, blood vessel lesions and lung fibrosis (which obstruct blood flow), and an enlargement of the right side of the heart. Ultimat

肺动脉高压（PH）是一种肺部疾病，其特征是肺部高压、血管壁增厚、血管病变和肺纤维化（阻碍血液流动），以及右侧心脏增大。那一